The San Francisco Bay Area's beleaguered life science market posted positive net absorption and a rebound in venture funding in the second quarter, according to Newmark, even as record vacancy, falling rents and a frozen construction pipeline showed how far recovery remains.
Thank you for your interest in The Registry. If you'd like to read further, you must Subscribe or Log In below to read the rest of this content.
Signup for news and special announcements!
You have successfully joined our subscriber list.
Prologis wants to tear down five aging North San Jose industrial buildings...
ByThe RegistrySeptember 28, 2026Essex Property Trust has lined up $275 million of unsecured bank debt...
ByThe RegistrySeptember 28, 2026Wells Fargo's latest economic outlook argues that a structurally higher floor under...
ByThe RegistrySeptember 28, 2026The San Francisco Bay Area captured more than $300 billion in expansion-stage...
ByThe RegistrySeptember 28, 2026